Lacrimal Duct Obstruction: Clinical Trials

3 trials for Lacrimal Duct Obstruction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1

Follow Lacrimal Duct Obstruction: new trials by email Literature Review of Lacrimal Duct Obstruction trials Research Report on Lacrimal Duct Obstruction

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
Artificial Tears Methylcellulose - Nasolacrimal Duct Obstruction, Thyroid Cancer
Phase 3RecruitingVanderbilt University Medical Center1002023-08-212025-10-28
Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old
Immediate Office Probing, Deferred Facility Probing - Nasolacrimal Duct Obstruction
Phase 3CompletedJaeb Center for Health Research2202008-10-012016-06-24
Monocanalicular Versus Bicanalicular Intubation in the Treatment of Congenital Nasolacrimal Duct Obstruction
Canalicular intubation - Nasolacrimal Duct Obstruction
Phase 3CompletedUniversity Hospital Ostrava702006-01-012015-03-04

Narrower conditions

Thyroid Neoplasms (1)

Broader conditions

Eye Diseases (3)  ·  Lacrimal Apparatus Diseases (3)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Thyroid Diseases (1)

Sponsors

Jaeb Center for Health Research (1)  ·  University Hospital Ostrava (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (2)  ·  Czechia (1)

Top investigators

Katherine A. Lee, M.D., Ph.D. (1)  ·  Pavel Kominek, MD,PhD,MBA (1)

Results publications

PMID 23229693

NIH funding

U10EY011751 (1)